-
Our Newest Pharmacologic Class for Treatment of Diabetes: SGLT2 Inhibitors
-
This cross-sectional studys purpose was to validate the Male Osteoporosis Risk Estimation Score (MORES) in a primary care setting; it had been previously validated in the National Health and Nutrition Examination Survey (NHANES) III.
-
Fluoroquinolones are commonly prescribed bactericidal agents with a wide spectrum of activity. In addition to the coverage against conventional gram-negative organisms, newer agents in this class have an expanded spectrum of activity against a variety of gram-positive and atypical organisms.
-
Dolutegravir, a once daily hiv-1 integrase strand transfer inhibitor (INSTI), has been approved by the FDA.
-
-
Regardless of the caffeine status, coffee intake was associated with reduced risk of type 2 diabetes while sugar-sweetened beverages were associated with a higher risk.
-
A new topical agent is available for the treatment of actinic keratosis (AK). Ingenol mebutate is a macrocyclic diterpene ester found in the sap of Euphorbia peplus, a common plant found in Africa, Europe, and Asia.
-
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.
-
The 12-lead ECG shown above was obtained from a 50-year-old man with new-onset chest pain. Is this ECG likely to represent a benign early repolarization pattern or the early stage of acute anterior ST elevation myocardial infarction (STEMI)?
-
Aspirin therapy, as compared with placebo, significantly reduced the rate of major vascular events with improved net clinical benefit and also reduced the rate of recurrent venous thromboembolism.
